New global lab network will compare vaccines head-to-head

In a network spanning Europe, Asia and North America, the labs will centralise analysis of samples from trials of Covid-19 candidates “as though vaccines are all being tested under one roof”, Saville said, aiming to minimise the risk of variation in results.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33pGFAr
via IFTTT